Provider notes

• NMUH:
• No restriction stated
• RFL:
• Not for intravenous use
• Microbiology/ID approval only
• RNOH:
• Non-formulary
• UCLH:
  
  • Approved for:
    
    • Cryptococcosis – treatment (Restricted to Microbiology approval)
    • Serious fungal infections (Restricted to Microbiology approval for intraventricular disease)
• WH:
• Non-formulary

Provider notes

• NMUH:
• As per Trust Guidelines
• RFL:
• Restricted to OLT prophylaxis (2nd transplant/hepatic artery thrombosis)
• Microbiology/ID approval required for all other indications
• RNOH:
• Microbiology approval only
• UCLH:
• WH:
• Microbiology approval only

Provider notes

• NMUH:
• Infusion restricted to Microbiology Consultants use only
• RFL:
• No restriction stated
• RNOH:
• No restriction stated
• UCLH:
• WH:
• Restricted antifungal. Microbiology approval only

Provider notes

• NMUH:
• Restricted to Microbiology Consultants use only
• RFL:
• Microbiology / ID approval required 
• RNOH:
• Non-formulary  
• UCLH:
• WH:
• Microbiology approval only

Provider notes

• NMUH:
• No restriction stated
• RFL:
• No restriction stated
• RNOH:
• Non-formulary  
• UCLH:
• WH:
• No restriction stated

Approved for treatment of proven or probable invasive aspergilosis or mucomycosis where other antifungals are not appropriate (JFC August 2020)

Provider notes

• NMUH:
• As per JFC decision above
• On microbiology recommendation ONLY
• RFL:
• Non-formulary
• RNOH:
• Non-formulary
• UCLH:
• WH:
• Non-formulary

Provider notes

• NMUH:
• No restriction stated
• RFL:
• Oral: Restricted to Dermatology; HIV; Haematology. ID/Microbiology approval for all other indications.
• Intravenous: Microbiology/ID approval
• RNOH:
• Microbiology approval only
• UCLH:
• WH:
• For restricted indications as per Trust guidelines or Microbiology advice

Provider notes

• NMUH:
• Liquid: Restricted to Haematology and Oncology for prophylaxis; Microbiology approval required for treatment doses and all other indications
• Tablets: Microbiology/ID approval required
• RFL:
• Liquid: Restricted to Haematology and Oncology for prophylaxis; Microbiology approval required for treatment doses and all other indications
• Tablets: Microbiology/ID approval required
• RNOH:
• Non-formulary
• UCLH:
• WH:
• Non-formulary

Provider notes

• NMUH:
• Restricted to Dermatology use only
• RFL:
• No restriction stated
• RNOH:
• No restriction stated
• UCLH:
• WH:
• No restriction stated

Provider notes

• NMUH:
• Microbiology approval required
• See MHRA Drug Safety Updates
• RFL:
• Microbiology approval required 
• RNOH:
  • Microbiology approval required
• UCLH:
• WH:
• Check with Microbiology

Provider notes

• NMUH:
  • Non-formulary
• RFL:
  • Microbiology / ID approval required
• RNOH:
  • Non-formulary
• UCLH:
• WH:
  • 500mg tablets

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

License withdrawn for this indication